Raise closed, search for fresh raises on Seedstage

Rochester, NY

Revolutionizing respiratory care with AI-powered personalized solutions for asthma and COPD.

• Mission: Enhancing respiratory care through AI-powered solutions for individuals with asthma and COPD, aiming to redefine how respiratory health is monitored and managed globally.  
• Innovation: AI-driven virtual platform and wearable devices that provide personalized, real-time respiratory monitoring, improving outcomes and reducing medication dependency.  
• Market Opportunity: Targeting the $83 billion respiratory care market, with a scalable solution for both consumer and clinical settings.  
• Technology: Advanced acoustics and machine learning enable continuous, always-on monitoring of respiratory health, predicting flare-ups and improving early diagnosis.  
• Strategic Partnerships: Collaborating with respiratory and behavioral health professionals to offer holistic care, while pursuing international partnerships to expand global reach.  
• Growth Potential: Positioned to meet growing demand with a strong waitlist and plans to make respiratory monitoring as accessible as basic health tools like thermometers.  

Health Care Originals (HCO) is a health technology company focused on enhancing respiratory care for individuals with asthma and chronic obstructive pulmonary disease (COPD), addressing a global market valued at $83 billion. Through its AI-driven virtual platform and wearable devices, HCO aims to deliver personalized respiratory management solutions that allow users to monitor and manage their conditions more effectively. This technology empowers users with real-time data, enabling better outcomes and reducing reliance on medication-only therapies.

With a waitlist of over 12,000 people, HCO’s goal for this fundraising is to expand its reach to meet the growing demand for its innovative platform. By achieving regulatory milestones and establishing international partnerships, HCO plans to make respiratory monitoring more accessible, similar to the ubiquity of thermometers. The company is driven to redefine respiratory care by improving early diagnosis and personalized management, creating a new standard for respiratory health in both consumer and clinical settings.

Company Info

Health Care Originals provides AI-powered, personalized respiratory care for asthma and COPD patients through a wearable device and virtual platform.

Health Care Originals (HCO) is a health technology company specializing in AI-powered respiratory care for managing asthma and chronic obstructive pulmonary disease (COPD). Using advanced acoustics and machine learning, HCO’s platform provides personalized, always-on monitoring that captures deep organ sounds, including coughs and breath sounds, to create a customized health baseline for each user. This approach enables real-time insights and helps predict potential flare-ups, offering users greater control over their respiratory health and reducing reliance on emergency care.

In addition to direct care, HCO partners with a network of respiratory and behavioral health professionals to support patients holistically. With a robust patent portfolio, including 13 granted patents and 10 pending, HCO aims to become a leader in respiratory care by serving a growing waitlist of patients and pursuing global partnerships. The platform’s continuous tracking and analytics model has shown promising results, with most users reporting fewer symptoms and hospital visits. HCO’s wearable device and platform offer a scalable solution within the $83 billion respiratory care market.